Wolfe Research raises Hexcel stock price target on strong earnings By Investing.com

Wolfe Research raised Hexcel's price target to $101 from $92 and kept an Outperform rating after the company delivered a strong Q1 2026 beat, with EPS of $0.59 versus $0.43 expected and revenue of $502 million versus $485.83 million expected. Shares rose 5% on the day and are up 84% over the past year, though guidance was not raised and the stock still screens as expensive at 63.6x earnings. The note highlights improving aircraft production trends and less risky A350 de-stocking, supporting a constructive near-term outlook.

Analysis

The market is treating HXL as a clean operating-leverage beneficiary to a production upcycle, but the more interesting point is that the valuation is now doing a lot of the heavy lifting. At ~64x earnings, the stock is no longer pricing a normal recovery; it is pricing sustained execution, stable mix, and no meaningful hiccup in aerospace build rates over the next 4-6 quarters. That makes the name highly sensitive to any soft patch in widebody programs or customer destocking, even if headline earnings remain strong.

The second-order read-through is that HXL is a downstream leverage play on aircraft OEM cadence, not on the macro air-travel/jet fuel narrative. If production rates continue improving, suppliers with cleaner operating leverage and less program concentration should outperform HXL on a relative basis, especially if investors start rotating toward names with lower multiples and more direct backlog visibility. The market may also be underestimating how much of the current enthusiasm is already embedded after an 84% run; from here, incremental good news has less room to re-rate the stock than to merely defend it.

The main risk is timing: aerospace supply-chain normalization usually plays out over quarters, while multiples can compress in days if management doesn’t lift guidance. If the A350 destock or other program-specific issues re-accelerate, the stock can de-rate quickly because the current multiple leaves little margin for error. Conversely, a clean guide-up at the next print could squeeze shorts, but that is a narrower setup than it looks because the market is already paying for the recovery.

Contrarian view: the consensus is extrapolating a cyclical recovery into a quasi-structural growth story. That is dangerous in a capital-intensive supplier where demand visibility is still mediated by OEM schedules, not end-demand alone. The better trade may be to own the recovery through cheaper peers or express the view with options rather than outright equity given how far the stock has already run.

Key Decisions for Investors

• Avoid initiating fresh outright longs in HXL here; at ~64x earnings, use pullbacks or post-earnings digestion only. Reward/risk is poor unless guidance materially improves.
• Express the constructive aerospace view via a relative-value pair: long a cheaper supplier with cleaner backlog visibility vs short HXL for 3-6 months. The goal is to capture the industry recovery while fading multiple compression risk.
• If already long HXL, trim 25-35% into strength and retain a core position only through the next guidance update. The upside is now more about multiple defense than multiple expansion.
• Use call spreads instead of stock if you want upside exposure into the next quarter. Structure should cap downside because the stock can re-rate down faster than fundamentals can catch up.
• Watch the next widebody production commentary as the key catalyst window; if A350-related noise returns, treat any 5-10% selloff as potentially the start of a de-rating rather than a buying opportunity.